Streetbeat News

Earnings

FIVE

Five Below shares are trading lower after the company reported worse-than-expected Q1 earnings and cut its guidance.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:07 am

LULU

Lululemon shares are trading higher following the company's better-than-expected Q1 financial results and the authorization of a $1 billion increase in its stock repurchase program.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:06 am

JFIN

Jiayin Group reported a Q1 loan facilitation volume of RMB22.5 billion ($3.1 billion), up 13.6% YoY. The average borrowing amount per borrowing increased by 6.6% to RMB10,570 ($1,464), and the repeat borrowing rate rose to 73.0% from 67.8% in the same period of 2023.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:05 am

HOFT

Hooker Furnishings anticipates short-term volatility in earnings due to an industry-wide downturn.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:05 am

JFIN

Jiayin Gr (NASDAQ:JFIN) reported Q1 earnings per share (EPS) of $0.72, a 5.26% decrease from $0.76 YoY. However, sales increased by 25.05% to $204.33 million from $163.40 million YoY.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:03 am

HOFT

Hooker Furnishings (NASDAQ:HOFT) reported a significant quarterly loss of $(0.39) per share, missing the analyst consensus estimate of $(0.03) by a wide margin. The company's sales also fell short of expectations, reporting $93.571 million against the estimated $94.941 million. Both earnings and sales have seen a substantial decline compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:01 am

APLD

CXM

FIVE

LPG

MASI

NKLA

SMMT

ZIM

Several major stocks, including Five Below, Sprinklr, Masimo, Dorian LPG, Nikola, ZIM Integrated Shipping Services, Summit Therapeutics, and Applied Digital, experienced significant declines in pre-market trading. Five Below posted weak Q1 results and lowered its FY guidance, leading to a sharp drop in its stock price.

Portfolio Pulse from Avi Kapoor

June 06, 2024 | 9:40 am

GILD

Gilead Sciences' Phase 2B MYR204 study showed promising results for Bulevirtide combined with Pegylated Interferon Alfa-2A in treating compensated chronic Hepatitis Delta Virus. 46% of patients achieved undetectable HDV RNA at week 24 post-treatment.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 9:23 am

QSG

QuantaSing Group (NASDAQ:QSG) reported Q3 earnings of $0.03 per share, missing the analyst estimate of $0.05 by 40%. However, the company reported sales of $130.96 million, beating the estimate of $128.51 million by 1.91%.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 9:04 am

NVDA

Nvidia Corp. (NASDAQ: NVDA) briefly surpassed a $3 trillion market cap, sparking debate about its true value. NYU Professor Aswath Damodaran believes Nvidia is overvalued but acknowledges its potential to reach $3 trillion. Nvidia's stock has surged over 54% since mid-2023, and the company will undergo a 10-for-1 stock split on Friday.

Portfolio Pulse from Shanthi Rexaline

June 06, 2024 | 8:23 am